News
Processa Pharmaceuticals entered into a binding term sheet with Intact Therapeutics for an exclusive option to license PCS12852 in a deal that includes $452.5 million in total milestone payments. RNA ...
Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...
It is tailored to patients being treated with Lilly's oncology drugs – which include blockbuster CDK 4/ 6 inhibitor Verzenio (abemaciclib) for hormone receptor-positive, HER2-negative breast ...
7d
Pharmaceutical Technology on MSNWhy can’t the US figure out weight loss drug prices?Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 receptor agonists (GLP-1RA), due to the emergence of compounded ...
Eli Lilly and Company (NYSE: LLY) today announced that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in single-dose vials for $499 per month ...
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
In its second R&D alliance this week, Eli Lilly has formed a partnership with Genetic Leap, a startup that focuses on applying artificial intelligence to the discovery of RNA-targeted therapies ...
Health news includes a cyberattack affecting patient care in London, Walgreens' financial success amid strategic changes, ...
12d
MedPage Today on MSNCombo Semaglutide-Amylin Analogue Boosts Weight Loss Regardless of DiabetesCHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...
10d
Pharmaceutical Technology on MSNHims & Hers shares plummet 35% as Novo Nordisk pulls partnership plugNovo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two ...
Oklahoma lawmakers passed HB 2048 to protect the 340B Drug Pricing Program, overriding a veto amid growing pressure from pharmaceutical interests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results